Catalent Inc (CTLT) Fundamental Analysis & Valuation

NYSE:CTLTUS1488061029

Current stock price

63.48 USD
0 (0%)
At close:
63.5 USD
+0.02 (+0.03%)
After Hours:

This CTLT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CTLT Profitability Analysis

1.1 Basic Checks

  • CTLT had positive earnings in the past year.
  • In the past year CTLT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CTLT reported negative net income in multiple years.
  • CTLT had a positive operating cash flow in each of the past 5 years.
CTLT Yearly Net Income VS EBIT VS OCF VS FCFCTLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • CTLT has a better Return On Assets (-4.25%) than 78.01% of its industry peers.
  • CTLT has a Return On Equity of -11.66%. This is in the better half of the industry: CTLT outperforms 75.92% of its industry peers.
Industry RankSector Rank
ROA -4.25%
ROE -11.66%
ROIC N/A
ROA(3y)-2.82%
ROA(5y)-0.09%
ROE(3y)-8.14%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A
CTLT Yearly ROA, ROE, ROICCTLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • CTLT has a Gross Margin (21.82%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of CTLT has declined.
  • The Profit Margin and Operating Margin are not available for CTLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.68%
GM growth 5Y-7.41%
CTLT Yearly Profit, Operating, Gross MarginsCTLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

3

2. CTLT Health Analysis

2.1 Basic Checks

  • CTLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CTLT has more shares outstanding
  • CTLT has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CTLT has a worse debt to assets ratio.
CTLT Yearly Shares OutstandingCTLT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CTLT Yearly Total Debt VS Total AssetsCTLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • CTLT has an Altman-Z score of 1.62. This is a bad value and indicates that CTLT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CTLT (1.62) is better than 64.92% of its industry peers.
  • The Debt to FCF ratio of CTLT is 49.84, which is on the high side as it means it would take CTLT, 49.84 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CTLT (49.84) is better than 78.01% of its industry peers.
  • CTLT has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of CTLT (1.38) is worse than 74.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 49.84
Altman-Z 1.62
ROIC/WACCN/A
WACC9.31%
CTLT Yearly LT Debt VS Equity VS FCFCTLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.51 indicates that CTLT has no problem at all paying its short term obligations.
  • CTLT's Current ratio of 2.51 is in line compared to the rest of the industry. CTLT outperforms 46.07% of its industry peers.
  • CTLT has a Quick Ratio of 1.93. This is a normal value and indicates that CTLT is financially healthy and should not expect problems in meeting its short term obligations.
  • CTLT has a Quick ratio (1.93) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 1.93
CTLT Yearly Current Assets VS Current LiabilitesCTLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. CTLT Growth Analysis

3.1 Past

  • CTLT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.40%.
  • Measured over the past years, CTLT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -33.48% on average per year.
  • CTLT shows a small growth in Revenue. In the last year, the Revenue has grown by 4.71%.
  • CTLT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.71% yearly.
EPS 1Y (TTM)-61.4%
EPS 3Y-56.51%
EPS 5Y-33.48%
EPS Q2Q%-30%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y3.1%
Revenue growth 5Y11.71%
Sales Q2Q%4.18%

3.2 Future

  • Based on estimates for the next years, CTLT will show a very strong growth in Earnings Per Share. The EPS will grow by 73.38% on average per year.
  • The Revenue is expected to grow by 7.44% on average over the next years.
EPS Next Y350.55%
EPS Next 2Y148.11%
EPS Next 3Y113.64%
EPS Next 5Y73.38%
Revenue Next Year8.33%
Revenue Next 2Y8.2%
Revenue Next 3Y8.33%
Revenue Next 5Y7.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTLT Yearly Revenue VS EstimatesCTLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CTLT Yearly EPS VS EstimatesCTLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4 5

4

4. CTLT Valuation Analysis

4.1 Price/Earnings Ratio

  • CTLT is valuated quite expensively with a Price/Earnings ratio of 288.55.
  • 78.01% of the companies in the same industry are more expensive than CTLT, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, CTLT is valued quite expensively.
  • CTLT is valuated quite expensively with a Price/Forward Earnings ratio of 41.25.
  • 76.44% of the companies in the same industry are more expensive than CTLT, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.69. CTLT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 288.55
Fwd PE 41.25
CTLT Price Earnings VS Forward Price EarningsCTLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CTLT is valued a bit cheaper than 76.96% of the companies in the same industry.
  • 78.53% of the companies in the same industry are more expensive than CTLT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 116.39
EV/EBITDA 36.47
CTLT Per share dataCTLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • CTLT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CTLT's earnings are expected to grow with 113.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y148.11%
EPS Next 3Y113.64%

0

5. CTLT Dividend Analysis

5.1 Amount

  • CTLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CTLT Fundamentals: All Metrics, Ratios and Statistics

Catalent Inc

NYSE:CTLT (12/17/2024, 8:52:12 PM)

After market: 63.5 +0.02 (+0.03%)

63.48

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-05
Earnings (Next)02-07
Inst Owners92.2%
Inst Owner Change0%
Ins Owners0.48%
Ins Owner Change0%
Market Cap11.52B
Revenue(TTM)4.42B
Net Income(TTM)-413.00M
Analysts52.86
Price Target64.77 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-149.78%
Min EPS beat(2)-336.02%
Max EPS beat(2)36.46%
EPS beat(4)1
Avg EPS beat(4)-365.14%
Min EPS beat(4)-1032.86%
Max EPS beat(4)36.46%
EPS beat(8)2
Avg EPS beat(8)-208.81%
EPS beat(12)5
Avg EPS beat(12)-141.22%
EPS beat(16)9
Avg EPS beat(16)-103.51%
Revenue beat(2)1
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-5.19%
Max Revenue beat(2)4.16%
Revenue beat(4)1
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-6.04%
Max Revenue beat(4)4.16%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)-0.33%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)0.11%
PT rev (3m)4.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.12%
EPS NY rev (1m)4.18%
EPS NY rev (3m)-6.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.9%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE 288.55
Fwd PE 41.25
P/S 2.61
P/FCF 116.39
P/OCF 28.88
P/B 3.25
P/tB 31.57
EV/EBITDA 36.47
EPS(TTM)0.22
EY0.35%
EPS(NY)1.54
Fwd EY2.42%
FCF(TTM)0.55
FCFY0.86%
OCF(TTM)2.2
OCFY3.46%
SpS24.36
BVpS19.51
TBVpS2.01
PEG (NY)0.82
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.25%
ROE -11.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.82%
FCFM 2.24%
ROA(3y)-2.82%
ROA(5y)-0.09%
ROE(3y)-8.14%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.68%
GM growth 5Y-7.41%
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 49.84
Debt/EBITDA 11.05
Cap/Depr 61.22%
Cap/Sales 6.78%
Interest Coverage N/A
Cash Conversion 90.27%
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 1.93
Altman-Z 1.62
F-Score5
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)125.99%
Cap/Depr(5y)159.79%
Cap/Sales(3y)11.57%
Cap/Sales(5y)13.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.4%
EPS 3Y-56.51%
EPS 5Y-33.48%
EPS Q2Q%-30%
EPS Next Y350.55%
EPS Next 2Y148.11%
EPS Next 3Y113.64%
EPS Next 5Y73.38%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y3.1%
Revenue growth 5Y11.71%
Sales Q2Q%4.18%
Revenue Next Year8.33%
Revenue Next 2Y8.2%
Revenue Next 3Y8.33%
Revenue Next 5Y7.44%
EBIT growth 1Y-166.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year196.68%
EBIT Next 3Y58.17%
EBIT Next 5Y41.23%
FCF growth 1Y121.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y116.85%
OCF growth 3Y-14.78%
OCF growth 5Y1.59%

Catalent Inc / CTLT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of Catalent Inc (CTLT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CTLT.


What is the valuation status of Catalent Inc (CTLT) stock?

ChartMill assigns a valuation rating of 4 / 10 to Catalent Inc (CTLT). This can be considered as Fairly Valued.


How profitable is Catalent Inc (CTLT) stock?

Catalent Inc (CTLT) has a profitability rating of 3 / 10.


What are the PE and PB ratios of Catalent Inc (CTLT) stock?

The Price/Earnings (PE) ratio for Catalent Inc (CTLT) is 288.55 and the Price/Book (PB) ratio is 3.25.


How sustainable is the dividend of Catalent Inc (CTLT) stock?

The dividend rating of Catalent Inc (CTLT) is 0 / 10 and the dividend payout ratio is 0%.